14.01% 7 Finance costs (13.10) (14.29) (1.19) (8.33%) Profit before income tax 78.33 43.35 34.98 80.69% Income tax (19.28) (8.18) 11.10 135.73% Profit for the period 59.05 35.17 23.88 67.90% Other
million or 18.5% from December 31, 2019. The important details of cash flow were as follows: 2.1.1 Cash and cash equivalent of Bt2,650.6 million which cash flow summarized for the period were below;- - The
customers. The bank will consider provide the loan types, the interest rate, limit loan types and payment period to appropriate with the customer business types and provided the loans considering process
Microsoft Word - ACE MDA Q3 23 - EN_R3 1 No. ACE-ACC-4/2023 14 November 2023 Subject Management Discussion and Analysis for the period ended 30 September 2023 To President The Stock Exchange of
from that of the same period of last year. Major Developments in 9M17 • Approved in the EGM 1/2016, in 1H17 the Company acquired 60% stake in NVD, previously called Daii Group Plc. (‘DAII”), through the
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company
(there has been no connected transaction occurred during the last six-month period). Therefore this transaction is not required (i) the Board of Directors approval; (ii) shareholders approval; and (iii
Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 31st March 2019 as follows. Summary